Key facts
| Price (PPV) | 182.10 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | simvastatine |
| Class | Lipid modifying agents |
| ATC code | C10AA01 |
| Manufacturer | AFRIC-PHAR |
| Presentation | Boîte de 60 |
| Nature | Médicament |
| Hospital price | 113.80 MAD |
| Data collected on | 9/8/2026 |
Indications
Hypercholestérolémies Traitement des hypercholestérolémies primaires ou des dyslipidémies mixtes, en complément du régime, lorsque la réponse au régime et aux autres traitements non pharmacologiques (par exemple, exercice physique, perte de poids) s'avère insuffisante. Traitement des hypercholestérolémies familiales homozygotes (HFHo) en complément du régime et des autres traitements hypolipidémiants (par exemple aphérèse des LDL) ou si de tels traitements sont inappropriés. Prévention cardiovasculaire Réduction de la mortalité et de la morbidité cardiovasculaires chez les patients ayant une pathologie cardiovasculaire avérée d'origine athéroscléreuse ou un diabète, avec cholestérol normal ou élevé en complément de l'effet de la correction des autres facteurs de risque et des autres traitements cardioprotecteurs.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Civastine 20 mg (BOTTU S.A.) contains the same active substance as Nocol 20 mg (Simvastatine) at the same strength, but in a different pack: Boîte de 30 at 94.30 MAD, i.e. 3.14 MAD per unit against 3.03 MAD for Nocol 20 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Civastine 20 mg | BOTTU S.A. | Boîte de 30 | 94.30 MAD | 3.14 / unit |
| Nocol 20 mg | AFRIC-PHAR | Boîte de 30 | 94.30 MAD | 3.14 / unit |
| Ransimva 20 mg | SUN PHARMACEUTICALS NORTH AFRICA S.A | Boite de 30 | 94.30 MAD | 3.14 / unit |
| Redlip 20 mg | ATLAS PHARM | Boîte de 30 | 94.30 MAD | 3.14 / unit |
| Zovas 20 mg | STERIPHARMA | Boîte de 30 | 94.30 MAD | 3.14 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Nocol 20 mg
Nocol 20 mg belongs to the lipid modifying agents therapeutic class. In Morocco, this drug is marketed by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Nocol 20 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Nocol 20 mg
Answers to common questions from Moroccan patients about this drug.